Registry for patients treated with extracorporeal organ support at Freiburg University Medical Center
The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry
This study collects information from patients receiving advanced life support treatments at Freiburg University Medical Center to help improve care for those with serious health issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Sex | All |
| Sponsor | University Hospital Freiburg Academic / other |
| Locations | 1 site (Freiburg im Breisgau) |
| Trial ID | NCT05811780 on ClinicalTrials.gov |
What this trial studies
This registry collects clinical and treatment data from patients receiving extracorporeal organ support, such as VV ECMO, VA ECMO, ECPR, Impella, and IABP, at the Department of Interdisciplinary Medical Intensive Care at the University of Freiburg Medical Center. The data is pseudonymized to ensure patient confidentiality while allowing for comprehensive analysis of treatment outcomes. The goal is to improve understanding and management of conditions requiring such advanced support.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients undergoing treatment with any form of extracorporeal organ support.
Not a fit: Patients not receiving extracorporeal organ support will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance treatment protocols and outcomes for patients requiring extracorporeal organ support.
How similar studies have performed: Other registries focusing on extracorporeal organ support have shown success in improving clinical outcomes and treatment strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Treatment with any kind of extracorporeal organ support Exclusion Criteria: * none
Where this trial is running
Freiburg im Breisgau
- University of Freiburg Medical Center — Freiburg im Breisgau, Germany (Recruiting)
Study contacts
- Principal investigator: Dawid L Staudacher, PD Dr. — University of Freiburg
- Study coordinator: Tobias Wengenmayer, Prof. Dr.
- Email: tobias.wengenmayer@uniklinik-freiburg.de
- Phone: +49761270
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.